S100A9 and leukemia: Biological experiments confirmed that S100a9/S100a8 conferred aselective advantage to the leukemia-initiating cells through autocrine effects andfacilitated immune evasion by recruiting and promoting immune suppressive myeloid-derivedsuppressor cells (MDSCs) in the microenvironment.